clinical outcomes of patients with ebv-ptld who fail rituximab following hsct
Published 2 years ago • 475 plays • Length 1:58Download video MP4
Download video MP3
Similar videos
-
6:01
update on allele: tab-cel in patients with ebv ptld following allosct after rituximab failure
-
1:56
strategies for the management of ebv-ptld
-
2:26
advances in ebv-ptld
-
3:36
outcomes of patients with newly diagnosed crlf2-rearranged b-all
-
8:57
outcomes of sct in t-all and t-lbl
-
4:10
cell care - dr friebe
-
7:53
diseases associated with the epstein-barr virus
-
10:37
ebv diagnostics
-
4:57
defifrance: outcomes of patients with post-hct vod/sos receiving defibrotide
-
3:16
tabelecleucel in the treatment of ebv ptld
-
3:29
tabelecleucel for treating ebv associated ptld
-
2:21
tab-cel for solid organ or allogeneic transplant recipients with ebv-ptld
-
2:24
the treatment and management of ptld
-
1:06
phase ib/ii study of viro-t-cell in patients with r/r cml infection after allosct
-
1:56
overview of the clinical management of patients with mf
-
1:13
outcomes following fd & nfd related donor haplo transplantation for patients with acute leukemias
-
1:01
clinical outcomes for patients with myelofibrosis after transition from ruxolitinib to momelotinib
-
1:21
response-adapted therapy with copanlisib and rituximab for previously untreated fl
-
1:35
outcomes of allosct following blinatumomab in children and young adults with r/r b-all
-
3:25
refined diagnostic criteria for sos/vod in adult patients: 2023 update by the ebmt
-
1:26
obe-cel for r/r b-all: pooled analysis of the ongoing felix study
-
3:03
outcomes following venetoclax monotherapy in patients with r/r wm in the real-world setting